A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Clinical trial NCT01369342 · COMPLETED

Trial details

NCT number: NCT01369342
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease Inflammatory Bowel Disease IBD Colitis

Start date: 2011-07-01
Primary completion: 2014-08-01
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.